col blocks we are bridge builder col blocks
COVID Antworten in den wissenschaftlichen Zeitschriften der Welt


58 Ergebisse       Seite 1

 [1] 
Wiley: Hepatology
  Original Artikel Datum Titel Autoren   Alle Autoren
1 [GO] 2024―Feb―15 Extensive splanchnic vein thrombosis after SARS-CoV-2 vaccination a Vascular Liver Disease Group (VALDIG) initiative Raoel Maan, Mandy N. Lauw, Loise China, David Patch, Anna Baiges, Juan Carlos Garcia-Pagan, et al. (+13)
2 [GO] 2023―Jul―17 Letter to the Editor: What is the actual role of decompensated cirrhosis in the breakthrough SARS-CoV-2 infection? Yue Hu, Zheng Li, Weilan He, Xin Wang, Xinran Cheng
3 [GO] 2023―Jul―17 Reply: What is the actual role of decompensated cirrhosis in the breakthrough SARS-CoV-2 infection? Jin Ge, Jean C. Digitale, Mark J. Pletcher, Jennifer C. Lai
4 [GO] 2023―Apr―10 Reply: progressive cholestasis and associated sclerosing cholangitis are complications of COVID-19 in patients with chronic liver disease Lukas Hartl, Thomas Reiberger, Michael Trauner
5 [GO] 2023―Apr―10 Letter to the editor: progressive cholestasis and associated sclerosing cholangitis are complications of COVID-19 in patients with chronic liver disease Sumayya Umar, Arsalan Nadeem, Muntaha Nadeem
6 [GO] 2023―Jan―27 The road to pandemic recovery: Tracking COVID-19’s impact on cirrhosis care and outcomes among 111,558 veterans Adeyinka C. Adejumo, Vera Yakovchenko, Timothy R. Morgan, Patrick Spoutz, Linda Chia, Jasmohan S. Bajaj, et al. (+3)
7 [GO] 2022―Sep―10 Breakthrough SARS-CoV -2 Infection Outcomes in Vaccinated Patients with Chronic Liver Disease and Cirrhosis: A N3C Study Jin Ge, Jean C. Digitale, Mark J. Pletcher, Jennifer C. Lai, Christopher G. Chute, Jeremy R. Harper, et al. (+4)
8 [GO] 2022―Sep―06 Postvaccination COVID-19 related mortality in patients with cirrhosis:who is the culprit? Zhihui Duan
9 [GO] 2022―Aug―24 COVID-19 related mortality in Cirrhosis is not associated with Proton Pump Inhibitor Exposure Binu V. John, Bassam Dahman
10 [GO] 2022―Aug―24 COVID-19 Vaccination and mortality in Decompensated Cirrhosis Binu V. John, Bassam Dahman
11 [GO] 2022―Aug―24 Could COVID-19 vaccination reduce post-infection mortality in most cirrhotic patients ? Gin-Ho Lo
12 [GO] 2022―Jul―12 Letter to the Editor: Complications following SARS-CoV-2 infection in patients with chronic liver disease Shi-Tao Jiang, Lei Zhang, Yi-Yao Xu, Xin Lu
13 [GO] 2022―Jun―17 Comparison of Infection-induced and Vaccine-induced Immunity Against Coronavirus 2019 in Patients with Cirrhosis Binu V. John, Akash Doshi, Raphaella D. Ferreira, Tamar H. Taddei, David E. Kaplan, Seth A. Spector, et al. (+3)
14 [GO] 2022―Mai―14 Liver injury after SARS-CoV -2 vaccination: Features of immune-mediated hepatitis, role of corticosteroid therapy and outcome Cumali Efe, Anand V. Kulkarni, Benedetta Terziroli Beretta-Piccoli, Bianca Magro, Albert Friedrich Stättermayer, Mustafa Cengiz, et al. (+46)
15 [GO] 2022―Apr―05 Letter to the editor: Clinical Features of Patients Infected With Coronavirus Disease 2019 With Elevated Liver Biochemistries: A Multicenter, Retrospective Study Ahmad hayat
16 [GO] 2022―Feb―17 Liver transplantation following SARS-CoV-2 vaccination-induced liver failure Cumali Efe, Murat Harputluoğlu, Neşe Karadağ Soylu, Sezai Yilmaz
17 [GO] 2022―Jan―13 Post-Vaccination COVID-19 Infection is Associated with Reduced Mortality in Patients With Cirrhosis Binu V. John, Yangyang Deng, Kaley B Schwartz, Tamar H. Taddei, David E. Kaplan, Paul Martin, et al. (+2)
18 [GO] 2021―Dez―14 Letter to the Editor: Autoimmune hepatitis after COVID-19 vaccination: Need for population based-epidemiological study Yuji Suzuki, Keisuke Kakisaka, Yasuhiro Takikawa
19 [GO] 2021―Dez―09 Reactivation of Hepatitis B virus triggered by SARS-COV2 in a cirrhotic patient Marta Librero Jiménez, María Ángeles López Garrido, María Carmen Fernández Cano
20 [GO] 2021―Dez―08 Effect of Increased Alcohol Consumption During COVID-19 Pandemic on Alcohol-related Liver Disease: A Modeling Study Jovan Julien, Turgay Ayer, Elliot B Tapper, Carolina Barbosa, William Dowd, Jagpreet Chhatwal
21 [GO] 2021―Dez―04 Letter to the editor: Exacerbation of autoimmune hepatitis after COVID-19 vaccination Zhujun Cao, Honglian Gui, Zike Sheng, Haiguang Xin, Qing Xie
22 [GO] 2021―Nov―19 Lettter to the editor on “Autoimmune hepatitis after COVID-19 vaccination” Rujittika Mungmunpuntipantip, Viroj Wiwanitkit
23 [GO] 2021―Sep―16 Letter to the editor: Autoimmune hepatitis after COVID-19 vaccination. A rare adverse effect? Panagiota Palla, Chrysovalantis Vergadis, Stratigoula Sakellariou, Theodoros Androutsakos
24 [GO] 2021―Aug―15 Reply to Letters to the Editor: Clinical outcomes in COVID-19 patients with current or past hepatitis B virus infection Terry Cheuk-Fung Yip, Vincent Wai-Sun Wong, Grace Lai-Hung Wong
25 [GO] 2021―Aug―13 Outcomes in chronic hepatitis B infection and COVID-19 - Not always benign ! Ankur Jindal
26 [GO] 2021―Aug―13 Letter to the Editor: unanswered questions about hepatitis B virus infection in patients with COVID-19 Xiu-He Lv, Jin-Lin Yang, Kai Deng
27 [GO] 2021―Jul―26 Impact of COVID-19 pandemic on liver transplantation and alcohol-associated liver disease in the United States George Cholankeril, Karthik Goli, Abbas Rana, Ruben Hernaez, Alexander Podboy, Prasun Jalal, et al. (+6)
28 [GO] 2021―Mai―09 Current and past infections of hepatitis B virus do not increase mortality in patients with COVID-19 Terry Cheuk-Fung Yip, Vincent Wai-Sun Wong, Grace Chung-Yan Lui, Viola Chi-Ying Chow, Yee-Kit Tse, Vicki Wing-Ki Hui, et al. (+4)
29 [GO] 2021―Apr―29 Letter to the Editor: Liver Biochemistries in Hospitalized Chinese Patients With Severe Coronavirus Disease 2019 Ya Gao, Ming Liu, Shuzhen Shi, Jinhui Tian
30 [GO] 2021―Mrz―13 Outcome of COVID-19 in Patients With Autoimmune Hepatitis: An International Multicenter Study Cumali Efe, Renumathy Dhanasekaran, Craig Lammert, Berat Ebik, Fatima Higuera-de la Tijera, Costica Aloman, et al. (+42)
31 [GO] 2021―Mrz―05 Letter to the Editor: Serum Albumin in COVID-19: A Good Example in Which Analytical and Clinical Performance of a Laboratory Test Are Strictly Intertwined Sara Pasqualetti, Elena Aloisio, Mauro Panteghini
32 [GO] 2021―Feb―14 AASLD Expert Panel Consensus Statement: Vaccines to Prevent COVID-19 Infection in Patients with Liver Disease Oren K. Fix, Emily A. Blumberg, Kyong-Mi Chang, Jaime Chu, Raymond T. Chung, Elizabeth K. Goacher, et al. (+16)
33 [GO] 2021―Feb―03 Covid-19 and liver cirrhosis: focus on the non-classical renin-angiotensin system and implications for therapy Giovanni Sansoè, Manuela Aragno, Florence Wong
34 [GO] 2020―Dez―18 Liver disease and COVID-19: from Pathogenesis to Clinical Care Antonio Saviano, Florian Wrensch, Marc G. Ghany, Thomas F. Baumert
35 [GO] 2020―Nov―24 Ketamine-Induced Sclerosing Cholangitis (KISC) in a Critically Ill Patient with COVID-19 Sally A.I. Knooihuizen, Ariel Aday, William M. Lee
36 [GO] 2020―Nov―21 Cirrhosis and SARS-CoV-2 infection in US Veterans: risk of infection, hospitalization, ventilation and mortality. George N. Ioannou, Peter S. Liang, Emily Locke, Pamela Green, Kristin Berry, Ann M. O’Hare, et al. (+5)
37 [GO] 2020―Nov―14 Letter to the Editors: More Efforts for Detecting the Elevated Liver Biochemistries in Patients with Severe COVID-19 Yi-Ming Lin, Ai-Yong Cui, Da-Wei Wang, Hua-Ding Lu
38 [GO] 2020―Nov―05 Addressing Social Determinants of Liver Disease during the COVID-19 Pandemic and Beyond: A Call to Action Ani Kardashian, Julius Wilder, Norah A. Terrault, Jennifer C. Price
39 [GO] 2020―Sep―27 Reply to Letter to the Editor: Elevated Liver Biochemistries in Hospitalized Chinese Patients With Severe COVID-19: Systematic Review and Meta-Analysis Alexander J. Kovalic, Glen Huang, Paul J. Thuluvath, Sanjaya K. Satapathy
40 [GO] 2020―Sep―23 Liver Injury in Liver Transplant Recipients with Coronavirus Disease 2019 (COVID-19): US Multicenter Experience Atoosa Rabiee, Brett Sadowski, Nia Adeniji, Ponni Perumalswami, Veronica Nguyen, Akshata Moghe, et al. (+21)
41 [GO] 2020―Aug―15 Maintaining Patient Safety and Data Integrity of NASH Clinical Trials During the SARS-CoV-2 Pandemic Naim Alkhouri, Anita Kohli, Rohit Loomba, Stephen A. Harrison
42 [GO] 2020―Aug―08 Letter to the Editors: COVID-19-Related Liver Injury: The Interpretation for Aspartate Aminotransferase Needs to Be Cautious Xiu-He Lv, Jin-Lin Yang, Kai Deng
43 [GO] 2020―Aug―08 Letter to the Editors: Statins and COVID-19: Efficacy Still to Be Proven Lucy Meunier, Magdalena Meszaros, Georges-Philippe Pageaux
44 [GO] 2020―Aug―02 Clinical Research in Hepatology in the COVID-19 Pandemic and Post-Pandemic Era: Challenges and the Need for Innovation Elizabeth C. Verna, Marina Serper, Jaime Chu, Kathleen Corey, Oren K. Fix, Karen Hoyt, et al. (+10)
45 [GO] 2020―Jul―29 Abnormal Liver Tests in COVID-19: A Retrospective Observational Cohort Study of 1827 Patients in a Major U.S. Hospital Network Melanie A. Hundt, Yanhong Deng, Maria M. Ciarleglio, Michael H. Nathanson, Joseph K. Lim
46 [GO] 2020―Jul―23 Abnormal liver function tests in COVID-19 patients: relevance and potential pathogenesis Anna Bertolini, Ivo P. van de Peppel, Frank A.J.A. Bodewes, Han Moshage, Alberto Fantin, Fabio Farinati, et al. (+5)
47 [GO] 2020―Jul―21 Elevated Liver Biochemistries in Hospitalized Chinese Patients with Severe COVID-19: Systematic Review and Meta-analysis Alexander J. Kovalic, Glen Huang, Paul J. Thuluvath, Sanjaya K. Satapathy
48 [GO] 2020―Jul―12 “Perioperative Presentation of COVID-19 Disease in a Liver Transplant Recipient” Thomas Reiberger, Mattias Mandorfer
49 [GO] 2020―Jul―03 Letter to the Editors: Additional Factors to Consider When Studying Liver Injury Indicators and Mortality in COVID-19 Patients Yanqing Liu
50 [GO] 2020―Jul―03 Letter to the Editor: COVID-19-Related Liver Injury and Clinical Outcomes: Does It Really Exist? Cyriac Abby Philips, Rizwan Ahamed, Philip Augustine
51 [GO] 2020―Jul―02 Reply to Letter to the Editor: COVID-19-Related Liver Injury and Clinical Outcomes: Does It Really Exist? Fang Lei, Ye-Mao Liu, Feng Zhou, Juan-Juan Qin, Xiaodong Huang, Bing-Hong Zhang, et al. (+2)
52 [GO] 2020―Jun―30 Clinical Features of COVID-19-Infected Patients With Elevated Liver Biochemistries: A Multicenter, Retrospective Study Yu Fu, Rui Zhu, Tao Bai, Ping Han, Qin He, Mengjia Jing, et al. (+9)
53 [GO] 2020―Mai―30 Acute Liver Injury in COVID-19: Prevalence and Association with Clinical Outcomes in a Large US Cohort Meaghan M. Phipps, Luis H. Barraza, Elijah D. LaSota, Magdalena E. Sobieszczyk, Marcus R. Pereira, Elizabeth X. Zheng, et al. (+3)
54 [GO] 2020―Mai―16 Liver Biochemistries in Hospitalized Patients With COVID-19 Patricia P. Bloom, Eric A. Meyerowitz, Zoe Reinus, Michael Daidone, Jenna Gustafson, Arthur Y. Kim, et al. (+2)
55 [GO] 2020―Mai―05 COVID-19 Hangover: A Rising Tide of Alcohol Use Disorder and Alcohol-Associated Liver Disease Ben L. Da, Gene Y. Im, Thomas D. Schiano
56 [GO] 2020―Apr―16 Clinical Best Practice Advice for Hepatology and Liver Transplant Providers During the COVID-19 Pandemic: AASLD Expert Panel Consensus Statement Oren K. Fix, Bilal Hameed, Robert J. Fontana, Ryan M. Kwok, Brendan M. McGuire, David C. Mulligan, et al. (+9)
57 [GO] 2020―Apr―10 Telemedicine in Liver Disease and Beyond: Can the COVID-19 Crisis Lead to Action? Marina Serper, Allen W. Cubell, Mary Elisabeth Deleener, Tara K. Casher, Dale J. Rosenberg, Dale Whitebloom, Roy M. Rosin
58 [GO] 2020―Mrz―27 Perioperative Presentation of COVID-19 Disease in a Liver Transplant Recipient Juanjuan Qin, Haitao Wang, Xuan Qin, Peng Zhang, Lihua Zhu, Jingjing Cai, et al. (+2)
 [1] 

58 Ergebisse       Seite 1


[de][en]

Letzte Änderung 2023―Okt―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.005 sec